FMR LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.

Quarter-by-quarter ownership
FMR LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$158,384,813
-61.7%
7,696,055
-12.4%
0.01%
-60.0%
Q2 2023$413,293,429
-30.5%
8,789,737
-38.0%
0.04%
+29.6%
Q1 2023$594,450,078
+137.9%
14,167,066
+116.2%
0.03%
+8.0%
Q4 2022$249,873,862
+1.0%
6,551,491
+3.7%
0.02%
-3.8%
Q3 2022$247,395,000
+28.1%
6,317,534
+5.7%
0.03%
+36.8%
Q2 2022$193,060,000
+3.6%
5,977,093
+6.1%
0.02%
+26.7%
Q1 2022$186,403,000
-20.2%
5,631,525
+2.6%
0.02%
-11.8%
Q4 2021$233,570,000
-6.5%
5,490,574
-2.6%
0.02%
-15.0%
Q3 2021$249,780,000
-35.9%
5,637,084
-17.8%
0.02%
-35.5%
Q2 2021$389,810,000
-40.5%
6,861,659
-21.6%
0.03%
-44.6%
Q1 2021$655,483,000
-2.9%
8,757,289
+12.2%
0.06%
-6.7%
Q4 2020$675,357,000
+41.7%
7,806,699
+0.1%
0.06%
+25.0%
Q3 2020$476,500,000
+47.2%
7,796,140
+0.1%
0.05%
+33.3%
Q2 2020$323,811,000
+44.8%
7,787,672
+0.0%
0.04%
+16.1%
Q1 2020$223,633,000
-60.1%
7,786,668
+0.2%
0.03%
-50.0%
Q4 2019$561,106,000
-48.4%
7,772,629
+0.3%
0.06%
-52.3%
Q3 2019$1,087,044,000
-22.6%
7,748,548
+1.0%
0.13%
-20.7%
Q2 2019$1,404,695,000
+16.1%
7,672,154
+0.8%
0.16%
+13.1%
Q1 2019$1,210,091,000
+79.6%
7,608,239
+8.2%
0.14%
+57.6%
Q4 2018$673,698,000
-31.9%
7,033,076
+0.5%
0.09%
-17.1%
Q3 2018$988,700,000
-9.5%
6,999,644
+0.3%
0.11%
-11.9%
Q2 2018$1,092,169,000
-1.3%
6,977,378
+1.6%
0.13%
-3.8%
Q1 2018$1,106,019,000
+7.7%
6,866,691
+10.1%
0.13%
+9.2%
Q4 2017$1,027,381,000
+193.6%
6,237,519
+11.1%
0.12%
+185.7%
Q3 2017$349,886,000
-21.6%
5,616,162
+0.3%
0.04%
-23.6%
Q2 2017$446,139,000
+12.3%
5,601,943
+0.2%
0.06%
+10.0%
Q1 2017$397,319,000
+39.6%
5,590,527
+0.3%
0.05%
+31.6%
Q4 2016$284,663,000
+12.9%
5,575,076
+1.8%
0.04%
+11.8%
Q3 2016$252,100,000
+74.2%
5,474,480
+13.9%
0.03%
+70.0%
Q2 2016$144,758,000
-5.9%
4,804,432
+0.1%
0.02%
-4.8%
Q1 2016$153,831,000
-39.0%
4,798,228
+10.9%
0.02%
-38.2%
Q4 2015$252,338,000
+38.0%
4,328,270
+0.1%
0.03%
+30.8%
Q3 2015$182,907,000
-41.2%
4,321,989
+1.3%
0.03%
-35.0%
Q2 2015$311,308,000
+60.1%
4,264,489
+10.2%
0.04%
+60.0%
Q1 2015$194,456,000
+37.3%
3,871,303
+0.1%
0.02%
+38.9%
Q4 2014$141,601,000
+16.6%
3,868,893
+0.3%
0.02%
+12.5%
Q3 2014$121,489,0003,856,7890.02%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
RTW INVESTMENTS, LP 5,149,482$105,976,3402.24%
Palo Alto Investors LP 1,005,776$20,698,8701.96%
Boxer Capital, LLC 1,094,000$22,514,5201.20%
Bellevue Group AG 3,513,351$72,304,7641.16%
PDT Partners, LLC 181,625$3,737,8430.47%
EASTERLY INVESTMENT PARTNERS LLC 195,643$4,026,3330.44%
Harvest Investment Services, LLC 30,302$623,6150.40%
Simplify Asset Management Inc. 120,030$2,470,2170.28%
SAMLYN CAPITAL, LLC 739,867$15,226,4630.25%
CAXTON ASSOCIATES LP 68,035$1,400,1600.19%
View complete list of SAGE THERAPEUTICS INC shareholders